SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-068325
Filing Date
2020-03-10
Accepted
2020-03-10 11:16:32
Documents
4
Period of Report
2020-03-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d892395d8k.htm 8-K 17329
2 EX-99.1 d892395dex991.htm EX-99.1 30944
3 GRAPHIC g892395g0310191401364.jpg GRAPHIC 2355
4 GRAPHIC g892395g0310191401624.jpg GRAPHIC 4350
  Complete submission text file 0001193125-20-068325.txt   58957
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 20700432
SIC: 2836 Biological Products, (No Diagnostic Substances)